Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure.
<h4>Background</h4>Biomarkers predicting tuberculosis treatment response and cure would facilitate drug development. This study investigated expression patterns of the co-stimulation molecule NKG2D in human tuberculosis and treatment to determine its potential usefulness as a host biomar...
Saved in:
| Main Authors: | Syeda S Hassan, Jang-Eun Cho, Muhammad Akram, Katherine L Fielding, Hazel M Dockrell, Jacqueline M Cliff |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0070063 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting LAG‐3 restores CD8+ T cell effector function through CD94/NKG2‐Qa‐1b signaling
by: Zhiqiang Wang, et al.
Published: (2024-12-01) -
IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells
by: Olivier Fesneau, et al.
Published: (2024-11-01) -
Lysosomal NKG7 restrains mTORC1 activity to promote CD8+ T cell durability and tumor control
by: Hyoungjun Ham, et al.
Published: (2025-02-01) -
CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors
by: Chiara Giordano, et al.
Published: (2025-01-01) -
Enhanced cytotoxicity of aging associated NKG2C + CD8 + T cells in ankylosing spondylitis via HLA-B27
by: Kunhai Tang, et al.
Published: (2025-06-01)